Travere Therapeutics TVTX
NASDAQ TVTX
$59.99 -1.58 (-2.57%)
At close: Sep 29, 2026 · 4:00 PM EDT

Travere Therapeutics (TVTX) Current Assets (2012 - 2026)

Updated

Travere Therapeutics' Current Assets came in at $615.14 million for Q2 2026, up 62.1% from $379.57 million a year earlier and up 56.7% from the prior quarter.

Analysis

Travere Therapeutics (TVTX) Current Assets (2012 - 2026) Analysis & Trends

At the end of FY2025, Travere Therapeutics' Current Assets was $437.57 million, up 5.0% from FY2024.

  • Current Assets carries a five-year compound annual growth rate of 1.3% (FY2020 to FY2025).
  • Going back by year, Current Assets was $416.7 million in FY2024 (-32.4%), $616.78 million in FY2023 (+26.8%), $486.44 million in FY2022 (-16.5%) and $582.83 million in FY2021 (+42.0%).
  • The Q2 2026 figure represents the highest quarterly Current Assets since Q4 2023.
  • Year-over-year, Current Assets has increased for five consecutive quarters, with an average decline of 2.3% over the last eight quarters.
  • The fastest year-over-year change in Current Assets over five years came in Q2 2026 (growth of 62.1%), and the weakest in Q3 2024 (a decline of 52.7%).
  • Business Quant data shows TVTX's Current Assets at $392.68 million (Q1 2026), $437.57 million (Q4 2025) and $371.11 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 59.77 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.67 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 27.35 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 27.97 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.96 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 13.95 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 41.36 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 12.54 Bn
10 Travere Therapeutics 5.80 Bn 5.40 Bn 167.41 Mn 615.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 615.14 Mn
Mar 31, 2026 392.68 Mn
Dec 31, 2025 437.57 Mn
Sep 30, 2025 371.11 Mn
Jun 30, 2025 379.57 Mn
Mar 31, 2025 374.17 Mn
Dec 31, 2024 416.70 Mn
Sep 30, 2024 324.74 Mn
Jun 30, 2024 368.98 Mn
Mar 31, 2024 481.08 Mn
Dec 31, 2023 616.78 Mn
Sep 30, 2023 686.23 Mn
Jun 30, 2023 542.06 Mn
Mar 31, 2023 604.90 Mn
Dec 31, 2022 486.44 Mn
Sep 30, 2022 534.84 Mn
Jun 30, 2022 586.78 Mn
Mar 31, 2022 631.09 Mn
Dec 31, 2021 582.83 Mn
Sep 30, 2021 579.08 Mn
API Access

Travere Therapeutics Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=TVTX&period=max&api_key=YOUR_API_KEY